PATENT CLAIM ANALYSIS

Application Number: 16008421
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "262100"]

Abstract:
Compounds of formula (I) and salts thereof: wherein R 1  is n-C 1-6 alkyl or C 1-2 alkoxyC 1-2 alkyl-, R 2  is halo, OH or C 1-3 alkyl, m is an integer having a value of 4, 5, 6 or 7, n is an integer having a value of 0, 1, 2 or 3, and p is an integer having a value of 0, 1 or 2, are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and asthma, infectious diseases and cancer, and may also be useful as vaccine adjuvants.

Claim (Index 20):
The method according to  claim 11  wherein the at least one other therapeutically active agent is selected from an antigen immunotherapy, an anti-histamine, a steroid, an NSAID, a bronchodilator, methotrexate, a leukotriene modulator, monoclonal antibody therapy, receptor therapy, and antigen non-specific immunotherapy.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.91549
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14423400', '14872620', '13973466', '14443932', '15370211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8058752800300986
- 35 USC 102 Novelty (BERT): 0.5662189366254705
- Combined Prediction Score: 0.7819096456896357
- Mean Citation Score: 423.33941
- Max Citation Score: 476.22415
- Similarity Product: 314.19557459632165

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test